Prescient Therapeutics Limited (ASX:PTX)
Australia · Delayed Price · Currency is AUD 0.0570
+0.0035 (6.54%)
May 12, 2026, 4:10 PM AEST
Prescient Therapeutics Market Cap
Prescient Therapeutics has a market cap or net worth of 56.26 million as of May 12, 2026. Its market cap has increased by 48.63% in one year.
Market Cap
56.26M
Enterprise Value
46.76M
Revenue
4.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.06
Market Cap Chart
Since March 5, 1998, Prescient Therapeutics's market cap has increased from 5.72M to 56.26M, an increase of 882.72%. That is a compound annual growth rate of 8.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 56.26M | -36.31% |
| Dec 31, 2025 | 88.33M | 119.36% |
| Dec 31, 2024 | 40.27M | -19.35% |
| Dec 29, 2023 | 49.93M | -48.68% |
| Dec 30, 2022 | 97.29M | -34.93% |
| Dec 31, 2021 | 149.52M | 248.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arovella Therapeutics | 91.87M |
| Immutep | 88.42M |
| Cynata Therapeutics | 79.55M |
| LTR Pharma | 79.07M |
| Botanix Pharmaceuticals | 73.45M |
| Radiopharm Theranostics | 67.34M |
| Amplia Therapeutics | 66.70M |
| Entropy Neurodynamics | 59.56M |